Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

OUTSET MEDICAL, INC.

(OM)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 09/24 02:48:27 pm
50.98 USD   -3.83%
09/20INSIDER SELL : Outset Medical
MT
09/16INSIDER SELL : Outset Medical
MT
09/08INSIDER SELL : Outset Medical
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Outset Medical : to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021

07/22/2021 | 04:11pm EDT

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter of 2021 after the close of trading on Thursday, August 5, 2021.

On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Leslie Trigg, Chief Executive Officer, and Nabeel Ahmed, Interim Chief Financial Officer, will host a conference call to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Thursday, August 5, 2021. Interested parties may access the live teleconference by dialing (833) 614-1409 for domestic callers or (914) 987-7130 for international callers, followed by conference ID: 7927579. A live and archived webcast of the event will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.


ę Business Wire 2021
All news about OUTSET MEDICAL, INC.
09/20INSIDER SELL : Outset Medical
MT
09/16INSIDER SELL : Outset Medical
MT
09/08INSIDER SELL : Outset Medical
MT
08/26OUTSET MEDICAL : to Present at Upcoming September Investor Conferences
BU
08/18OUTSET MEDICAL : Cowen Starts Outset Medical at Outperform With $70 Price Target
MT
08/12Outset Medical Announces Transition of Nabeel Ahmed from Interim Chief Financial Office..
CI
08/09OUTSET MEDICAL : Morgan Stanley Adjusts Outset Medical's Price Target to $55 from $60, Kee..
MT
08/06OUTSET MEDICAL : Management's Discussion and Analysis of Financial Condition and Results o..
AQ
08/05OUTSET MEDICAL : Earnings Flash (OM) OUTSET MEDICAL Posts Q2 Revenue $25.2M, vs. Street Es..
MT
08/05OUTSET MEDICAL : Earnings Flash (OM) OUTSET MEDICAL Reports Q2 Loss $-0.57, vs. Street Est..
MT
More news
Analyst Recommendations on OUTSET MEDICAL, INC.
More recommendations
Financials (USD)
Sales 2021 99,6 M - -
Net income 2021 -138 M - -
Net cash 2021 283 M - -
P/E ratio 2021 -17,6x
Yield 2021 -
Capitalization 2 455 M 2 455 M -
EV / Sales 2021 21,8x
EV / Sales 2022 16,1x
Nbr of Employees 313
Free-Float 99,3%
Chart OUTSET MEDICAL, INC.
Duration : Period :
Outset Medical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OUTSET MEDICAL, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 53,01 $
Average target price 63,00 $
Spread / Average Target 18,8%
EPS Revisions
Managers and Directors
Leslie L. Trigg President, Chief Executive Officer & Director
Nabeel Ahmed Chief Financial & Accounting Officer
D. Keith Grossman Chairman
Michael Aragon Chief Medical Officer
Jean-Olivier Racine Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
OUTSET MEDICAL, INC.-6.74%2 455
THERMO FISHER SCIENTIFIC30.24%239 289
DANAHER CORPORATION45.91%232 039
INTUITIVE SURGICAL, INC.27.72%124 326
SIEMENS HEALTHINEERS AG41.83%78 425
EDWARDS LIFESCIENCES CORPORATION31.16%75 435